Literature DB >> 25189117

Linkage analysis and whole-exome sequencing exclude extra mutations responsible for the parkinsonian phenotype of spinocerebellar ataxia-2.

Chaodong Wang1, Yanming Xu2, Xiuli Feng3, Jinghong Ma4, Shu Xie3, Yanli Zhang5, Bei-Sha Tang6, Piu Chan7.   

Abstract

CAG expansion within the exon 1 of ataxin-2 (ATXN2) gene responsible for spinocerebellar ataxia-2 (SCA2) has been reported to cause pure parkinsonism and other neurodegenerative disorders. However, it remains unclear whether CAG expansion is the only cause for SCA2 and its clinical alternatives, and whether extra mutations exist to modify the phenotypic diversity. To address this, we have conducted fine genetic mapping and exome sequencing for a large Chinese SCA2 pedigree predominantly manifesting parkinsonism (called SCA2-P). In addition, we compared the CAG expansions between the SCA2-P and 16 SCA2 families presenting as pure ataxia (SCA2-A). As a result, CAG repeat expansions, ranging from 37 to 40 copies, were detected among 10 affected and 8 nonsymptomatic members of the SCA2-P family. The CAG repeats in the diseased alleles were interrupted by CAA in the 3'-end. In contrast, CAG expansion ranging from 36 to 54 without CAA interruption was detected in all probands of the SCA2-A families. Genetic mapping located the SCA2-P pedigree on 12q24.21, which spans the ATXN2 gene. Exome sequencing for 3 patients and 1 normal member revealed no extra mutations in this family. In addition, by genotyping single-nucleotide polymorphisms around SCA2 locus, we have excluded the existence of haplotypes predisposing different patterns of CAG expansion. These results demonstrate that the ATXN2 CAG expansion is the sole causative mutation responsible for SCA2-P, and that genetic modifiers may not be the major cause of the phenotypic diversity of SCA2.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Linkage analysis; Mutation; Parkinsonism; Spinocerebellar ataxia-2; Whole-exome sequencing

Mesh:

Substances:

Year:  2014        PMID: 25189117     DOI: 10.1016/j.neurobiolaging.2014.07.039

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  6 in total

1.  Differentially Expressed Circular RNAs in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease.

Authors:  Stylianos Ravanidis; Anastasia Bougea; Dimitra Karampatsi; Nikolaos Papagiannakis; Matina Maniati; Leonidas Stefanis; Epaminondas Doxakis
Journal:  Mov Disord       Date:  2021-01-12       Impact factor: 10.338

2.  ATXN2 a culprit with multiple facets.

Authors:  Aurore Nkiliza; Marie-Christine Chartier-Harlin
Journal:  Oncotarget       Date:  2017-05-23

3.  Spinocerebellar ataxia 2 in a family with different phenotypes: Two case reports.

Authors:  Yuanyuan Li; Ying Chang; Xiufeng Liu; Yanyan Li; Yayun Yan
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 4.  What is the Pathogenic CAG Expansion Length in Huntington's Disease?

Authors:  Jasmine Donaldson; Sophie Powell; Nadia Rickards; Peter Holmans; Lesley Jones
Journal:  J Huntingtons Dis       Date:  2021

5.  Parkinson's disease associated with pure ATXN10 repeat expansion.

Authors:  Birgitt Schüle; Karen N McFarland; Kelsey Lee; Yu-Chih Tsai; Khanh-Dung Nguyen; Chao Sun; Mei Liu; Christie Byrne; Ramesh Gopi; Neng Huang; J William Langston; Tyson Clark; Francisco Javier Jiménez Gil; Tetsudo Ashizawa
Journal:  NPJ Parkinsons Dis       Date:  2017-09-05

6.  A Novel Duplication in ATXN2 as Modifier for Spinocerebellar Ataxia 3 (SCA3) and C9ORF72-ALS.

Authors:  Martin Paucar; Per Svenningsson; Jose Miguel Laffita-Mesa; Inger Nennesmo
Journal:  Mov Disord       Date:  2020-10-15       Impact factor: 10.338

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.